Evidence map›Paper›PMID 40643817›Full record

ReviewCEN case reports2025

Tubulointerstitial nephritis with predominant monotypic plasma cell infiltration in three cases of Sjögren's syndrome: case reports and literature review.

Hiroaki Miyauchi, Tatsuhiko Azegami, Akinori Hashiguchi, Mika Misaki, Takahisa Kawaguchi, Hironari Hanaoka, Mizuho Muramatsu, Takayoshi Soga, Takashi Ando, Eiji Kubota and 6 more

Abstract readCase ReportsReview
In one paragraph

Review in CEN case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hiroaki MiyauchiDivision of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Tatsuhiko AzegamiDivision of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. t.azegami-1114@keio.jp.ORCID 0000-0002-4809-5788
Akinori HashiguchiDepartment of Pathology, Keio University School of Medicine, Tokyo, Japan.
Mika MisakiDivision of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Takahisa KawaguchiDivision of Nephrology, Department of Internal Medicine, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Kanagawa, Japan.
Hironari HanaokaDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Mizuho MuramatsuDepartment of Internal Medicine, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan.
Takayoshi SogaDepartment of Internal Medicine, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan.
Takashi AndoDivision of Nephrology, Department of Internal Medicine, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Kanagawa, Japan.
Eiji KubotaDepartment of Internal Medicine, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan.
Takashin NakayamaDivision of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Norifumi YoshimotoDivision of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Akihito HishikawaDivision of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Aika HagiwaraDivision of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Yuko KanekoDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Kaori HayashiDivision of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tubulointerstitial nephritis (TIN) is a common kidney manifestation of Sjögren's syndrome, typically characterized by interstitial infiltration of T and B cells, with plasma cells being more prominent than in other etiologies. While most plasma cell infiltration in TIN is polytypic and the importance of the immunoglobulin isotypes expressed by the infiltrating plasma cells in the pathogenesis is unknown, recent reports have identified rare cases with monotypic IgA-positive plasma cell infiltration accompanied by monoclonal gammopathy of undetermined significance (MGUS). Here, we present three cases of Sjögren syndrome-associated TIN characterized by monotypic plasma cell infiltration. In all cases, the isotype of the infiltrating plasma cells was consistent with that of the predominant serum immunoglobulin. One patient exhibited IgA-type MGUS, one had IgM-type MGUS, and one showed elevated serum IgG levels along with IgG-positive plasma cell infiltration, but without detectable paraproteinemia. Notably, serum immunoglobulin levels decreased in parallel with improvement in kidney function. These findings suggest a potential link between the systemic immunoglobulin profile and local immunopathology of the kidneys in Sjögren's syndrome. Further case accumulation is needed to clarify the clinical significance and pathophysiology of monotypic plasma cell infiltration in TIN associated with Sjögren's syndrome.

Indexed as

Nephritis, InterstitialPlasma CellsSjogren's SyndromeAgedFemaleHumansKidneyMaleMiddle AgedPlasma cellSjögren's syndromeTubulointerstitial nephritis

Identifiers

PMID40643817
PMCPMC12457239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.